Adial Pharmaceuticals (ADIL) Q3 2023 Earnings

14NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-1.33
-0.89
-0.44
0

Details

Expected EPS
-1.13
Actual EPS
-1.14
Surprise EPS
-0.01
Surprise Percent
+0.88%

Description

Adial Pharmaceuticals (ADIL) has reported earnings of -1.14 per share for Q3 2023.

0 Comments

Share your thoughts